What is the recommended treatment for H pylori (Helicobacter pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for H. pylori Infection

Bismuth quadruple therapy for 14 days is the recommended first-line treatment for H. pylori infection in regions with high clarithromycin resistance (>15-20%). 1

First-Line Treatment Options

Preferred Regimens

  1. Bismuth quadruple therapy (14 days)

    • PPI + bismuth + tetracycline + metronidazole
    • Eradication rate: approximately 85%
    • Recommended in regions with high clarithromycin resistance (>15-20%)
  2. Concomitant non-bismuth quadruple therapy (14 days)

    • PPI + clarithromycin + amoxicillin + metronidazole
    • Eradication rate: approximately 80%
    • Alternative first-line option
  3. Standard triple therapy (14 days)

    • PPI + amoxicillin + clarithromycin
    • Eradication rate: approximately 85%
    • Only recommended in regions with low clarithromycin resistance (<15-20%)
    • FDA-approved regimen: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily for 14 days 2

Important: All H. pylori eradication regimens should now be given for 14 days to improve eradication success 1, 3

Second-Line Treatment Options

After failure of first-line therapy, consider:

  1. Bismuth quadruple therapy (if not used as first-line)

    • PPI + bismuth + tetracycline + metronidazole for 14 days
  2. Levofloxacin-based triple therapy

    • PPI + amoxicillin + levofloxacin for 14 days

Third-Line Treatment Options

For refractory cases with two failed therapies:

  1. Rifabutin-based triple therapy

    • PPI + amoxicillin + rifabutin for 14 days
  2. High-dose dual therapy

    • High-dose PPI + amoxicillin

Note: After two failed therapies with confirmed patient adherence, H. pylori susceptibility testing should guide subsequent regimen selection 1

Administration Guidelines

  • PPI should be taken 30 minutes before eating or drinking on an empty stomach
  • Avoid concomitant use of other antacids (e.g., H2 receptor antagonists)
  • Amoxicillin should be taken at the start of a meal to minimize gastrointestinal intolerance 2
  • For dual therapy (alternative option): 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily for 14 days 2

Confirmation of Eradication

  • Wait at least 4 weeks after completing antibiotic therapy before testing for H. pylori eradication
  • Recommended tests:
    • Urea Breath Test (UBT) - gold standard non-invasive test (sensitivity 95%, specificity 90%)
    • Monoclonal stool antigen test - alternative with equivalent accuracy

Special Considerations

  • Antibiotic resistance: Major cause of treatment failure; review patient's antibiotic exposure history before selecting a regimen
  • Patient adherence: Critical for successful eradication; ensure patients understand the importance of completing the full course
  • Penicillin allergy: Consider bismuth quadruple therapy without amoxicillin
  • Renal impairment: Patients with GFR <30 mL/min should NOT receive the 875 mg dose of amoxicillin 2

Common Pitfalls to Avoid

  1. Using standard triple therapy in areas with high clarithromycin resistance
  2. Prescribing shorter treatment courses (7-10 days instead of 14 days)
  3. Failing to confirm eradication after treatment
  4. Repeating the same regimen after initial treatment failure
  5. Not considering antibiotic resistance patterns when selecting therapy

The treatment landscape for H. pylori has evolved significantly due to increasing antibiotic resistance, making traditional triple therapy less effective in many regions. Quadruple therapies should now play a more prominent role in eradication efforts 3, 4, 5.

References

Guideline

H. pylori Gastritis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.